Predictive value of telomerase reverse transcriptase expression in patients with high risk superficial bladder cancer treated with adjuvant BCG immunotherapy

Journal of Cancer Research and Clinical Oncology

Volumn 135, Issue 9, 2009, Pages 1169-1175

  Zachos, Ioannis ^a   Konstantinopoulos, Panagiotis A ^b,c   Vandoros, Gerasimos P ^d   Karamouzis, Michalis V ^b   Papatsoris, Athanasios G ^b,e   Podimatas, Thomas ^d   Papachristodoulou, Antonios ^e   Chrisofos, Michael ^e   Deliveliotis, Charalambos ^e   Papavassiliou, Athanasios G ^b,e  

^a UNIVERSITY OF THESSALY   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d UNIVERSITY GENERAL HOSPITAL OF PATRAS   (Greece)

^e UNIVERSITY OF ATHENS   (Greece)

Author keywords

BCG; Multivariate analysis; Recurrence; SuperWcial bladder cancer; Telomerase reverse transcriptase

Indexed keywords

BCG VACCINE; TELOMERASE REVERSE TRANSCRIPTASE;

ADULT; AGED; ANALYSIS; ARTICLE; BLADDER CANCER; CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER IMMUNOTHERAPY; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CYSTECTOMY; DISEASE COURSE; EVALUATION; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MULTIVARIATE ANALYSIS; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; SALVAGE THERAPY; STAINING; TRANSURETHRAL RESECTION; TREATMENT FAILURE;

ADJUVANTS, IMMUNOLOGIC; AGED; AGED, 80 AND OVER; BCG VACCINE; DISEASE-FREE SURVIVAL; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RISK FACTORS; TELOMERASE; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 68549141398     PISSN: 01715216     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00432-009-0557-9     Document Type: Article

References (32)

1. EH Blackburn 1991 Structure and function of telomeres Nature 350 569 573 10.1038/350569a0
2. H Brustmann 2005 Immunohistochemical detection of human telomerase reverse transcriptase (hTERT) and c-kit in serous ovarian carcinoma: a clinicopathologic study Gynecol Oncol 98 396 402 10.1016/j.ygyno.2005.04.035 (Pubitemid 41169150)
3. KY Chen LN Lee CJ Yu 2006 Elevation of telomerase activity positively correlates to poor prognosis of patients with non-small cell lung cancer Cancer Lett 240 148 156 10.1016/j.canlet.2005.09.005 (Pubitemid 44037180)
4. P Dalerba C Guiducci PL Poliani 2005 Reconstitution of human telomerase reverse transcriptase expression rescues colorectal carcinoma cells from in vitro senescence: evidence against immortality as a constitutive trait of tumor cells Cancer Res 65 2321 2329 10.1158/0008-5472.CAN-04-3678 (Pubitemid 40490142)
5. J Domont TM Pawlik V Boige 2005 Catalytic subunit of human telomerase reverse transcriptase is an independent predictor of survival in patients undergoing curative resection of hepatic colorectal metastases: a multicenter analysis J Clin Oncol 23 3086 3093 10.1200/JCO.2005.06.944 (Pubitemid 46224132)
6. T Dutu S Michiels P Fouret 2005 Differential expression of biomarkers in lung adenocarcinoma: a comparative study between smokers and never-smokers Ann Oncol 16 1906 1914 10.1093/annonc/mdi408 (Pubitemid 41724279)
7. AE Elkak G Meligonis M Salhab 2005 hTERT protein expression is independent of clinicopathological parameters and c-Myc protein expression in human breast cancer J Carcinog 4 17 10.1186/1477-3163-4-17 (Pubitemid 41548697)
8. KT Etheridge SS Banik BN Armbruster 2002 The nucleolar localization domain of the catalytic subunit of human telomerase J Biol Chem 277 24764 24770 10.1074/jbc.M201227200 (Pubitemid 34952008)
9. ML Falchetti F Pierconti P Casalbore 2003 Glioblastoma induces vascular endothelial cells to express telomerase in vitro Cancer Res 63 3750 3754
10. T Fujioka M Hasegawa Y Suzuki 2000 Telomerase activity in human renal cell carcinoma Int J Urol 7 16 21 10.1046/j.1442-2042.2000.00130.x (Pubitemid 30162861)
11. HW Herr PC Sogani 2001 Does early cystectomy improve the survival of patients with high risk superficial bladder tumors? J Urol 166 1296 1299 10.1016/S0022-5347(05)65756-4
12. HW Herr RA Badalament DA Amato 1989 Superficial bladder cancer treated with Bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression J Urol 141 22 29
13. HW Herr DM Schwalb ZF Zhang 1995 Intravesical Bacillus Calmette-Guerin therapy prevents tumor progression and death from superficial bladder cancer: ten-year follow-up of a prospective randomized trial J Clin Oncol 13 1404 1408
14. Z Kirkali T Chan M Manoharan 2005 Bladder cancer: epidemiology, staging and grading, and diagnosis Urology 66 4 34 10.1016/j.urology.2005.07.062 (Pubitemid 43049607)
15. T Kobayashi K Kubota T Takayama 2001 Telomerase activity as a predictive marker for recurrence of hepatocellular carcinoma after hepatectomy Am J Surg 181 284 288 10.1016/S0002-9610(01)00566-9 (Pubitemid 32480232)
16. K Kraemer S Fuessel U Schmidt 2003 Antisense-mediated hTERT inhibition specifically reduces the growth of human bladder cancer cells Clin Cancer Res 9 3794 3800
17. DL Lamm JI DeHaven J Shriver 1991 Prospective randomized comparison of intravesical with percutaneous Bacillus Calmette-Guerin versus intravesical Bacillus Calmette-Guerin in superficial bladder cancer J Urol 145 738 740
18. S Lantuejoul JC Soria D Moro-Sibilot 2004 Differential expression of telomerase reverse transcriptase (hTERT) in lung tumours Br J Cancer 90 1222 1229 10.1038/sj.bjc.6601643 (Pubitemid 38496817)
19. S Lantuejoul JC Soria L Morat 2005 Telomere shortening and telomerase reverse transcriptase expression in preinvasive bronchial lesions Clin Cancer Res 11 2074 2082 10.1158/1078-0432.CCR-04-1376 (Pubitemid 40471874)
20. CT Lee RL Dunn C Ingold 2007 Early-stage bladder cancer surveillance does not improve survival if high-risk patients are permitted to progress to muscle invasion Urology 69 1068 1072 10.1016/j.urology.2007.02.064 (Pubitemid 46891598)
21. JR Reed M Vukmanovic-Stejic JM Fletcher 2004 Telomere erosion in memory T cells induced by telomerase inhibition at the site of antigenic challenge in vivo J Exp Med 199 1433 1443 10.1084/jem.20040178 (Pubitemid 38685734)
22. F Saint L Salomon R Quintela 2003 Do prognostic parameters of remission versus relapse after Bacillus Calmette-Guerin (BCG) immunotherapy exist? Analysis of a quarter century of literature Eur Urol 43 351 360 10.1016/S0302-2838(03)00048-4 (discussion 360-361) (Pubitemid 36427453)
23. H Saitoh K Mori S Kudoh 2002 BCG effects on telomerase activity in bladder cancer cell lines Int J Clin Oncol 7 165 170 10.1007/s101470200024 (Pubitemid 34733482)
24. JW Shay WE Wright 1996 The reactivation of telomerase activity in cancer progression Trends Genet 12 129 131 10.1016/0168-9525(96)30018-8 (Pubitemid 26114764)
25. T Shinka A Hirano Y Uekado 1990 Clinical study of prognostic factors of superficial bladder cancer treated with intravesical Bacillus Calmette-Guerin Br J Urol 66 35 39 10.1111/j.1464-410X.1990.tb14861.x (Pubitemid 20227994)
26. DL Smith JC Soria L Morat 2004 Human telomerase reverse transcriptase (hTERT) and Ki-67 are better predictors of survival than established clinical indicators in patients undergoing curative hepatic resection for colorectal metastases Ann Surg Oncol 11 45 51 10.1007/BF02524345
27. B Usselmann M Newbold AG Morris 2001 Telomerase activity and patient survival after surgery for gastric and oesophageal cancer Eur J Gastroenterol Hepatol 13 903 908 10.1097/00042737-200108000-00005 (Pubitemid 32757006)
28. O Uziel E Fenig J Nordenberg 2005 Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines Br J Cancer 92 1881 1891 10.1038/sj.bjc.6602592 (Pubitemid 40826137)
29. A Van Der Meijden R Sylvester L Collette 2000 The role and impact of pathology review on stage and grade assessment of stages Ta and T1 bladder tumors: a combined analysis of 5 European Organization for Research and Treatment of Cancer Trials J Urol 164 1533 1537 10.1016/S0022-5347(05)67022-X
30. YL Wu C Dudognon E Nguyen 2006 Immunodetection of human telomerase reverse-transcriptase (hTERT) re-appraised: nucleolin and telomerase cross paths J Cell Sci 119 2797 2806 10.1242/jcs.03001 (Pubitemid 44184016)
31. Y Yang Y Chen C Zhang 2002 Nucleolar localization of hTERT protein is associated with telomerase function Exp Cell Res 277 201 209 10.1006/excr.2002.5541 (Pubitemid 34757101)
32. AR Zlotta JC Noel I Fayt 1999 Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with Bacillus Calmette-Guerin intravesical therapy J Urol 161 792 798 10.1016/S0022-5347(01)61770-1 (Pubitemid 29422368)